COVID-19: Intensive care management.
Revue Medicale Suisse
; 16(691):863-868, 2020.
Artículo
en Francés
| EMBASE | ID: covidwho-20238148
ABSTRACT
The SARS-coronavirus 2 disease initially reported in December 2019 in China (COVID-19) represents a major challenge for intensive care medicine, due to the high number of ICU admission and the prolonged stay for many patients. Up to 5% of COVID-19 infected patients develop severe acute hypoxemic respiratory failure requiring invasive mechanical ventilation as supportive treatment. Apart from early antiviral and anti-inflammatory treatment, the management of COVID-19 patients is mainly applying protective mechanical ventilation, to support the injured lungs. However recently acquired data and clinical experience suggest that COVID-19-related ARDS presents some specificities that will be summarized in the present article.Copyright © 2020 Editions Medecine et Hygiene. All rights reserved.
acute hypoxemic respiratory failure; adult respiratory distress syndrome; antiviral therapy; article; artificial ventilation; coronavirus disease 2019; hospital admission; human; intensive care; intensive care medicine; intensive care unit; invasive ventilation; antiinflammatory agent; antivirus agent
Texto completo:
Disponible
Colección:
Bases de datos de organismos internacionales
Base de datos:
EMBASE
Tipo de estudio:
Estudio pronóstico
Idioma:
Francés
Revista:
Revue Medicale Suisse
Año:
2020
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS